UM Today UM Today University of Manitoba UM Today UM Today UM Today
News from
Rady Faculty of Health Sciences
UM Today Network
University of Manitoba ALS researchers reseasrch

Dr. Jiming Kong (Principal Investigator); Dr. Mike Namaka; and Dr. Hassan Marzban. The UofM team was awarded $1.6 million to pursue ALS research. // Photo by Garrick Kozier

Making a Splash

U of M ALS Researchers Benefit from Ice Bucket Challenge

November 19, 2015 — 

A University of Manitoba research team investigating a cure for amyotrophic lateral sclerosis (ALS) was awarded $1.6 M as one of only five Canadian research teams selected for a translational team grant.

On Nov. 19, ALS Societies across Canada and the ALS Canada Research Program, in partnership with Brain Canada, announced $15 million in funding to be invested amongst research teams across Canada to support ALS research.

The largest allocation was to the $10.15 million Arthur J. Hudson Translational Team Grants (Hudson Grant), awarded to five teams of researchers spanning academic institutions across Canada including research led by Principal investigator Dr. Jiming Kong, University of Manitoba ($1.6 M) into the removal of a toxic protein through a simple injection into the bloodstream rather than an injection into spinal fluid.

Dr. Kong, professor of human anatomy & cell science, Max Rady College of Medicine, Rady Faculty of Health Sciences is conducting the research with Dr. Mike Namaka, associate professor, College of Pharmacy and Dr. Hassan Marzban, assistant professor, human anatomy & cell science from the University of Manitoba, Dr. Yu Tian Wang of UBC and Dr. Xin-min Li of University of Alberta.

Kong, whose been studying ALS for more than 20 years, says successful completion of his team’s project could lead to an Investigative New Drug (IND) application and clinical trials.

ALSMB-infographic-english (3)“This funding is therefore timely and critically important for us to move our research one step further towards a cure for the disease,” says Kong, adding, “There are a number of world-class ALS researchers in Canada. We are fortunate and extremely honoured to be selected as one of the five teams to receive this significant funding.”

In total, 34 projects are being funded through today’s announcements and represent 56 investigators at 15 universities throughout Canada. The astounding $15-M in funding being allocated is a ten-fold increase over historic investments, and was made possible by funds raised during the ALS Ice Bucket Challenge. This news commemorates the one year anniversary of ALS Canada and Brain Canada announcing their partnership to allocate dollars to advance ALS research in Canada.

“This is a great example of grass roots involvement in a worthy cause and we thank the ALS Canada Research Program for supporting our research here at the University of Manitoba,” says Dr. Brian Postl, Dean, Faculty of Health Sciences. “We are proud of the innovative and collaborative research – like Dr. Kong’s- fostered in the Faculty of Health Sciences, and the far-reaching impact it may have on combatting deadly diseases such as ALS.”

ALS Canada notes the research being funded “represents the most promising science in Canada and will aid in accelerating the development of effective treatments for those affected by ALS.”

Following ALS Canada Research Program announcements, the ALS Society of Manitoba will be providing local advancements. Over $350,000 was raised in Manitoba and will now play a pinnacle role in the national research.

Along with the funds allocated to research, an additional $4.4 million raised by the 2014 Ice Bucket Challenge was invested to support the day-to-day care of Canadians living with ALS. Approximately 2,500 to 3,000 Canadians are living with ALS today, and the average cost for caring for one person with ALS is between $150,000 and $250,000.

Research at the University of Manitoba is partially supported by funding from the Government of Canada Research Support Fund.

, , , ,

© University of Manitoba • Winnipeg, Manitoba • Canada • R3T 2N2

Emergency: 204-474-9341